Related Experiment Video
Updated: May 7, 2026
08:42
Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Published on: July 18, 2008
16.2K
Case Report: Decoding genetic risks of vascular parkinsonism: a case series
Ali Shalash1, Salma El-Shafie2, Peter George1
1Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Frontiers in Genetics
|August 11, 2025
Summary
Genetic analysis reveals novel risk variants for vascular parkinsonism (VaP), distinct from typical Parkinson's disease genes. This study deepens our understanding of VaP's complex genetic underpinnings.
Area of Science:
- Genetics
- Neurology
- Medical Research
Background:
- Vascular parkinsonism (VaP) is a subtype of parkinsonism requiring better characterization of its risk factors and determinants.
- Understanding the genetic landscape of VaP is crucial for accurate diagnosis and therapeutic development.
Observation:
- Whole Exome Sequencing (WES) was performed on five participants diagnosed with VaP.
- Deleterious variants in genes associated with vascular and parkinsonian diseases were analyzed.
Findings:
- Several candidate risk variants for VaP were identified in genes such as LRRK2, PLA2G6, TGM6, BSN, UBR4, CD36, and NOTCH3.
- These identified variants differ from those typically associated with classical Parkinson's disease.
Implications:
- The genetic contributions to VaP are complex, involving variants in genes linked to parkinsonism, cerebrovascular disease, and collagen.
- This research provides a foundation for future studies investigating the genetic etiology of VaP.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...